Dermatology Times

NOVEMBER 3, 2023

Polyphenols, found in certain foods, have antioxidant and anti-inflammatory properties may help modulate immune responses, offering potential adjunctive therapy for atopic dermatitis, psoriasis, and chronic urticaria.

Dermatology 74

Dermatology Dermatitis Therapy 74

Dermatology Times

NOVEMBER 20, 2024

aureus in atopic dermatitis. ENS-002 targets S.

Dermatitis 73

Dermatitis Therapy 73

First Derm

FEBRUARY 21, 2024

Treatment Approaches Vary : Treatment for eczema includes emollients and topical steroids, while psoriasis may be treated with light therapy, systemic medications, and biologics, emphasizing the need for personalized care. Contact dermatitis from metals, latex, chemicals. 2] Why is Eczema Considered a Chronic Condition?

Eczema 59

Eczema Dermatitis Medical Management 59

Dermatology Times

DECEMBER 24, 2024

James Song, MD, FAAD, discusses how recent advancements in atopic dermatitis treatment include targeted biologics and Janus kinase inhibitors that offer promising alternatives to traditional therapies for patients with moderate-to-severe disease.

Dermatitis 36

Dermatitis Therapy Treatments 36

First Derm

JUNE 10, 2024

Online Dermatologist Atopic Dermatitis vs. Contact Dermatitis: What’s the Difference? Atopic dermatitis (left) and contact dermatitis (right) display different symptoms. Contact Dermatitis : Triggered by external irritants or allergens, causing localized redness, blisters, and itching.

Dermatitis 45

Dermatitis Irritation Eczema Dry Skin 45

Dermatology Times

JANUARY 8, 2025

Experts explore innovative therapies, psychosocial impacts, and education strategies for managing atopic dermatitis in a Dermatology Times video series.

Dermatitis 41

Dermatitis Innovations Education Therapy 41

Dermatology Times

SEPTEMBER 18, 2024

From dupilumab to OX40s, Zirwas talked about the niche to all atopic dermatitis therapies to make the best decision with your patient.

Dermatitis 41

Dermatitis Therapy 41

Dermatology Times

APRIL 11, 2024

In one study, researchers were unable to detect any changes in the gut microbiome of patients treated with tapering dose of steroids or a probiotic mixture.

Dermatitis 81

Dermatitis Therapy 81

Dermatology Times

MARCH 4, 2024

Test your knowledge on the AAD's recommendations for phototherapy, monoclonal antibodies, JAK inhibitors, and systemic therapies in the latest guidelines.

Dermatitis 73

Dermatitis Therapy 73

The Dermatology Digest

MARCH 7, 2024

More Conference Coverage Welcome to the Golden Age of Pediatric Dermatology Elizabeth Swanson, MD Elizabeth (Lisa) Swanson, MD, a pediatric dermatologist in Boise, ID, discusses advances in treating kids with atopic dermatitis, psoriasis, vitiligo, alopecia areata, and hemangiomas. appeared first on The Dermatology Digest.

Dermatitis 74

Dermatitis Dermatology Therapy 74

The Dermatology Digest

DECEMBER 13, 2024

Food and Drug Administration (FDA) has approved nemolizumab (Nemluvio, Galderma) for the treatment of patients aged 12 and older with moderate to severe atopic dermatitis, in combination with topical corticosteroids (TCS) and/or calcineurin inhibitors (TCI) when the disease is not adequately controlled with topical prescription therapies.

Dermatitis 69

Dermatitis Safety Eczema Dermatology 69

Dermatology Times

FEBRUARY 17, 2024

Investigators revealed the development of a non-invasive molecular test utilizing gene expression differences in skin diseases such as atopic dermatitis, psoriasis, and mycosis fungoides, with the potential to accurately diagnose and identify super-responders to targeted systemic therapies.

Dermatitis 87

Dermatitis Therapy 87

The Dermatology Digest

MARCH 7, 2024

Adam Friedman, MD, Professor and Chair of Dermatology at George Washington School of Medicine and Health Sciences in Washington, DC, offers up advice on how to work up and treat patients with chronic spontaneous urticaria (CSU). Watch Now SOCS Turns 20! Taylor, MD Skin of Color Society Founder Susan C.

Dermatitis 69

Dermatitis Dermatology Therapy 69

Dermatology Times

OCTOBER 27, 2024

At Fall Clinical 2024, Christopher Bunick, MD, PhD, discussed systemic therapy options and the importance of comprehensive treatment targets in managing atopic dermatitis, emphasizing AHEAD recommendations and LEVEL UP data.

Dermatitis 53

Dermatitis Treatments Therapy Management 53

The Dermatology Digest

FEBRUARY 14, 2024

Food and Drug Administration (FDA) has accepted Galderma’s Biologics License Applications for nemolizumab for the treatment of patients with prurigo nodularis (PN) and for adolescents and adults with moderate to severe atopic dermatitis (AD). Galderma is planning for multiple regulatory submissions in 2024.

Dermatitis 78

Dermatitis Clinic Safety Dermatology 78

The Dermatology Digest

DECEMBER 11, 2024

Im really excited about the clinical possibilities of this research, says senior author Daniel Kaplan, MD, PhD, Professor of Dermatology and Immunology at the University of Pittsburgh in Pittsburgh, PA, in a news release. There are no good therapies for flushing, so this is a significant unmet need.

Therapy 41

Therapy Rosacea Entrepreneurship Eczema 41

Dermatology Times

DECEMBER 12, 2023

At the 2023 RAD Virtual Conference, Chovatiya presented a session titled, "Living the Cream."

Dermatitis 74

Dermatitis Therapy 74

Dermatology Times

AUGUST 27, 2024

The AHEAD recommendations focus on achieving disease control in atopic dermatitis by allowing patients to identify key symptoms and clinicians to select matching outcomes to guide therapy, aiming for a higher standard of care.

Dermatitis 45

Dermatitis Treatments Therapy 45

The Dermatology Digest

FEBRUARY 26, 2024

2 In this review, we highlight the “epithelial barrier hypothesis” proposed by Akdis, discuss the important roles of the skin, gut, and respiratory barriers, and discuss novel therapies. Impairment in tight junction expression has been shown to contribute to the barrier dysfunction observed in patients with atopic dermatitis.

Dermatitis 74

Dermatitis Irritation Therapy Moisturization 74

Dermatology Times

DECEMBER 7, 2023

A patient returns to your clinic seeking systemic therapy for her AD while postpartum and breastfeeding. Test your knowledge on injectables.

Management 73

Management Dermatitis Injections Therapy 73

Dermatology Times

OCTOBER 3, 2023

As cold weather is approaching for much of the country, it is crucial for dermatologists, pediatricians, and families to work together for proper pediatric atopic dermatitis care.

Social Media 74

Social Media Dermatitis Therapy 74

Dermatology Times

JANUARY 8, 2024

The topical therapy was more effective in patients with psoriasis and AD when compared to a vehicle control cream.

Dermatitis 80

Dermatitis Therapy 80

The Dermatology Digest

MARCH 11, 2024

Emma Guttman-Yassky, MD, PhD, the Waldman Professor of Dermatology and Immunology and Health System Chair of Dermatology at the Icahn School of Medicine at Mount Sinai in New York City, shares results from a late-breaker that she presented at the annual meeting of the American Academy of Dermatology in San Diego, CA.

Dermatitis 69

Dermatitis Eczema Dermatology Pharmaceutical 69

Dermatology Times

DECEMBER 11, 2023

From the December cover feature: Christopher Bunick, MD, PhD; Aaron Drucker, MD, ScM; and Mona Shahriari, MD, share their thoughts on AAD’s updated atopic dermatitis guidelines.

Management 73

Management Dermatitis Therapy 73

Dermatology Times

DECEMBER 31, 2024

A panelist discusses how precision medicine enables targeted atopic dermatitis treatments by matching specific therapies to patients based on their unique disease characteristics and biomarkers

Dermatitis 36

Dermatitis Treatments Therapy 36

Dermatology Times

JUNE 2, 2024

James Song, MD, explains combination treatment efficacy, addresses comorbidities, and provides pearls to improve patient safety.

Dermatitis 52

Dermatitis Therapy Safety Treatments 52

Dermatology Times

MAY 30, 2024

Lawrence Eichenfield, MD, discusses the numerous limitations of current topical treatments for atopic dermatitis (AD), their impact on patient management, adherence, and quality of life, the common obstacles patients face in achieving adequate disease control with these therapies, and compares ruxolitinib cream as a nonsteroidal monotherapy alternative. (..)

Dermatitis 72

Dermatitis Therapy Management Treatments 72

First Derm

APRIL 5, 2024

Ensuring adherence to therapies in dermatology is paramount for enhancing treatment efficacy and promoting patient well-being. Prevalence of Poor Adherence Poor adherence is a significant issue in dermatology, leading to suboptimal treatment outcomes, disease exacerbation, and prolonged recovery periods.

Dermatology 45

Dermatology Treatments Education Medical 45

Dermatology Times

DECEMBER 24, 2024

James Song, MD, FAAD, discusses how improving patient adherence to atopic dermatitis treatments requires addressing barriers such as cost, treatment complexity, and patient education, while highlighting how emerging therapies and simplified regimens may help overcome these challenges in the future.

Dermatitis 36

Dermatitis Treatments Education Therapy 36

Dermatology Times

AUGUST 9, 2024

Explore how surveyed providers perceive current and emerging therapies in the atopic dermatitis.

Dermatitis 41

Dermatitis Treatments Therapy 41

Dermatology Times

DECEMBER 22, 2023

The study findings were presented in a poster at the 2023 Revolutionizing Atopic Dermatitis Virtual Conference.

Dermatitis 74

Dermatitis Therapy 74

Dermatology Times

JULY 24, 2024

A recent study saw a “significant” decrease in allergen-specific IgE levels over a 1-year period of dupilumab therapy in children with atopic dermatitis.

Management 41

Management Dermatology Dermatitis Therapy 41

Dermatology Times

JULY 13, 2024

A significant proportion of pediatric patients with AD achieved and maintained clinical remission with dupilumab, according to a poster presented at the SPD's annual meeting.

Dermatitis 57

Dermatitis Therapy Clinic 57

Dermatology Times

DECEMBER 10, 2024

Panelists discuss how managing atopic dermatitis presents complex clinical challenges, including treatment resistance, medication adherence, identifying triggers, and tailoring therapies to individual patient needs and disease severity.

Dermatitis 36

Dermatitis Clinic Therapy Management 36

US Dermatologt Partners

NOVEMBER 25, 2023

Atopic dermatitis (AD) is a multifaceted condition that can significantly impact a patient’s quality of life. In a candid conversation between Jennifer Holman, MD, FAAD, who practices at US Dermatology Partners in Tyler, Texas, and Audrey Dean, a patient who has navigated this complex condition.

Dermatitis 36

Dermatitis Therapy Networking Treatments 36

Dermatology Times

JANUARY 2, 2025

A panelist discusses how diagnostic differentiation of prurigo nodularis requires careful examination of the characteristic firm, hyperkeratotic nodules and consideration of the patient's history of chronic pruritus and scratching behavior, while noting that comorbid atopic dermatitis may influence treatment selection toward dual-targeting therapies. (..)

Dermatitis 36

Dermatitis Management Therapy Treatments 36

Dermatology Times

MARCH 29, 2024

Brian Kim, MD, explores long-term ruxolitinib data and combination therapies in the treatment of pediatric atopic dermatitis.

Therapy 36

Therapy Dermatitis Treatments 36